Cardlytics, Inc. CDLX

Rank #1835 · Nasdaq · $0.1B market cap

Audited by DELOITTE & TOUCHE LLP, no going-concern flag in the latest filing.

Score

41.0

P/E

-0.8

P/B

0.48

ROE

-63.7%

Op. Margin

-43.9%

Debt Ratio

153%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -0.8x, P/B 0.48x. Ranks in the top 51% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -63.7%. Ranks in the top 88% of the universe.

Safety ★★☆☆☆

Average

Debt ratio 153%. Ranks in the top 54% of the universe.

Growth ★★☆☆☆

Average

Revenue growth of 3.6% year over year. Ranks in the top 54% of the universe.

Valuation is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2018	$0.1B	$-0.1B	$-0.1B	$-0.2B	-49.8	-162
2019	$0.1B	$-0.0B	$-0.0B	$-0.2B	-13.1	-171
2020	$0.2B	$-0.0B	$-0.1B	$-0.2B	-27.2	-39
2021	$0.2B	$-0.0B	$-0.0B	$0.1B	-8.2	511
2022	$0.2B	$-0.1B	$-0.1B	$0.1B	-28.9	400
2023	$0.3B	$-0.1B	$-0.1B	$0.2B	-45.9	305
2024	$0.3B	$-0.5B	$-0.5B	$0.7B	-153.3	64
2025	$0.3B	$-0.1B	$-0.1B	$0.2B	-43.9	153